Westside Investment Management, Inc.
Position in ACXP — Acurx Pharmaceuticals, Inc.
CIK 1538383
SANTA MONICA, CA
Position in ACXP
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,557
-$3,564 QoQ
Shares Held
1,650
0.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 19 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACXP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Westside Investment Management, Inc. holds $2,010,311 across 23 Biotechnology names. ACXP ranks #20 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KZIA |
Kazia Therapeutics Ltd
|
47,585 | $669,996 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
6,140 | $334,875 | |
| 3 | LTRN |
Lantern Pharma Inc.
|
47,850 | $199,534 | |
| 4 | INMB |
Inmune Bio, Inc.
|
108,300 | $176,529 | |
| 5 | ANIX |
Anixa Biosciences Inc
|
43,000 | $120,400 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
181 | $112,860 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
179 | $88,914 | |
| 8 | ARGX |
Argenx SE
|
60 | $55,666 |
All Filings in ACXP
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,557 | 1,650 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,121 | 1,650 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||